What is Maestro-03 MBP8298-SP?

Category: Others

false

Phase III double-blind, placebo controlled multi-center study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Maestro-03 MBP8298-SP

Side effect Patients

Why patients stopped taking Maestro-03 MBP8298-SP

Multiple reasons could be selected

Reason Patients
Personal research 1
See 1 patient who's stopped using Maestro-03 MBP8298-SP

Duration

Stopped using Maestro-03 MBP8298-SP

Duration Patients
1 - 2 years 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:

1 patient evaluation for Maestro-03 MBP8298-SP

Jun 9, 2009 (Started Jun 03, 2008)

  • Effectiveness
    Can’t tell (for Other)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 2 other Yearly
Advice & Tips: This was a phase III study and was stopped because it did not show any major improvement.
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Maestro-03 MBP8298-SP